Skip to main content

PBYI- Puma Biotechnology, Inc.

Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.

PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

RoleInsiderSharesValue30d
CEO7.26M$64.70M-
CFO240.0K$2.14M-
Other205.3K$1.83M-
Dir54.0K$481.1K-

Activity

Buys and sells only

Transactions

10 filings · page 19
DateInsiderRoleTypeSharesPriceValueChg%SEC
Dec 2, 2019Bryce Richard PaulSee RemarksSell83$10.34$858.23-0.2%
Dec 2, 2019Auerbach Alan H62President And CEOSell455$10.33$4,699.65-
Nov 4, 2019Bryce Richard PaulSee RemarksSell88$7.38$649.45-0.2%
Nov 4, 2019Auerbach Alan H62President And CEOSell478$7.40$3,537.21-
Oct 2, 2019Bryce Richard PaulSee RemarksSell91$10.05$914.55-0.2%
Oct 2, 2019Auerbach Alan H62President And CEOSell504$9.97$5,027.15-
Sep 12, 2019Hunt Douglas M62See RemarksSell1,711$11.42$19,539.62-11.9%
Sep 4, 2019Auerbach Alan H62President And CEOSell524$10.14$5,313.36-
Sep 4, 2019Bryce Richard PaulSee RemarksSell95$10.11$960.45-0.3%
Aug 2, 2019Auerbach Alan H62President And CEOSell517$9.03$4,668.49-

Understand these filings